Y-Intercept (HK)’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
+11,849
New +$776K 0.03% 939
2026
Q1
Sell
-7,991
Closed -$138K 1512
2025
Q4
$138K Buy
7,991
+4,504
+129% +$87.3K ﹤0.01% 1461
2025
Q3
$89.8K Buy
+3,487
New +$132K ﹤0.01% 1496
2025
Q2
Sell
-1,785
Closed -$193K 1602
2025
Q1
$193K Buy
+1,785
New +$155K 0.01% 1067
2024
Q2
Sell
-918
Closed -$140K 1339
2024
Q1
$140K Buy
+918
New +$153K 0.01% 1218
2023
Q4
Sell
-607
Closed -$269K 1190
2023
Q3
$269K Buy
+607
New +$274K 0.03% 805
2023
Q2
Sell
-1,052
Closed -$624K 1228
2023
Q1
$624K Buy
+1,052
New +$589K 0.07% 421
2022
Q4
Sell
-743
Closed -$435K 963
2022
Q3
$435K Sell
743
-1,244
-63% -$745K 0.04% 583
2022
Q2
$1.08M Buy
1,987
+1,555
+360% +$786K 0.14% 205
2022
Q1
$274K Sell
432
-109
-20% -$56.2K 0.06% 483
2021
Q4
$365K Buy
+541
New +$329K 0.09% 337

Other funds holding AGL

Y-Intercept (HK)'s AGL Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Agilon Health (AGL) in Q2 2026: 11,849 shares worth $1.27M. The stake represents 0.03% of the portfolio and ranks #939 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in AGL as recently as Q4 2025.

Y-Intercept (HK) first reported a position in AGL in Q4 2021 and has held it in 11 quarters since. 19 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Y-Intercept (HK) held 11,849 shares of Agilon Health worth $1.27M as of Q2 2026.
  • Agilon Health was a new Y-Intercept (HK) position in Q2 2026.
  • Agilon Health made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #939 holding.
  • Y-Intercept (HK) first reported a position in Agilon Health in Q4 2021 and has held it in 11 quarters since.
  • 19 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.